STAT3 and cystic fibrosis: Transcription of Nrf-2 is sensitive to a number of regulatory mechanisms [13], including ones found to be dysfunctional in CF, such as lipid processing [20]–[22], [24], [27], and protein inhibitor of activated STAT3 activity [28].